Moreover, the coadministration of gefitinib with MBX-2982 did not reduce the tumor volume in xenografts implanted with shGPR119-MCF-7 cells (Fig 5c), which imply that GPR119 signaling is required for anti-cancer effect of MBX-2982. This evidence concerns the gene GPR119 and cancer.